Waldenström's macroglobulinemia primary prevention

Waldenström's macroglobulinemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Waldenström's macroglobulinemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Bone Marrow Aspiration and Biopsy
Electrophoresis and Immunofixation
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Waldenström's macroglobulinemia primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Waldenström's macroglobulinemia primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Waldenström's macroglobulinemia primary prevention
CDC on Waldenström's macroglobulinemia primary prevention
Waldenström's macroglobulinemia primary prevention in the news
Blogs on Waldenström's macroglobulinemia primary prevention
Directions to Hospitals Treating Waldenström's macroglobulinemia
Risk calculators and risk factors for Waldenström's macroglobulinemia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] {AE}} Mirdula Sharma, MBBS [2]

Primary prevention of Waldenström's macroglobulinemia depends on the type of risk factor causing the disease.

Modifiable risk factors

• Hepatitis C

Non-modifiable risk factors

• Age > 50
• Male gender
• Race - White
• Hereditary- Monoclonal gammopathy of undetermined significance